PDF format only. Topics: Knee Prostheses

continue reading.....

The FDA is is publishing a list of premarket approval applications (PMAs) that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMAs through the Internet and…

continue reading.....

Concert Pharmaceuticals, Inc. announced today that it has initiated a Phase I study in healthy volunteers to evaluate the safety, tolerability and pharmacokinetics of CTP-347, a novel deuterium-containing serotonin modulator created by Concert researchers.

continue reading.....

Scientists at the University of Leicester have published findings about a new advance in the study of major diabetes drug target.

continue reading.....

Policing is dangerous work, and the danger lurks not on the streets alone. The pressures of law enforcement put officers at risk for high blood pressure, insomnia, increased levels of destructive stress hormones, heart problems, post-traumatic stress disorder (PTSD) and suicide, University at Buffalo researchers have found through a decade of studies of police officers.

continue reading.....

WASHINGTON, September 25, 2008 -According to a report released today by AARP, drug manufacturers have substantially raised prices on the 144 specialty drugs most commonly used by people in Medicare Part D.
The latest AARP Rx Watchdog Report, from…

continue reading.....

The FDA has approved immune globulin [human, 10%] intravenous infusion, iobenguane I 123 intravenous injection, and a new pen cartridge strength for somatropin [rDNA origin] injection.
Medscape Medical News

continue reading.....

Results of a randomized trial confirm a “modest but significant” benefit from thrombolytic therapy given up to 4.5 hours after stroke onset, but the goal of early treatment is still emphasized.
Medscape Medical News

continue reading.....

End-of-Phase 2A Meetings

continue reading.....

Many factors can affect the efficacy and safety of cancer treatments, not the least of which are drug-drug and drug-disease interactions associated with duplicate, OTC, and CAM medications.

NCCN Clinical Practice Oncology Forum

continue reading.....